Ketamine for Chronic Pain

Ketamine and Chronic Pain

Chronic pain — defined as pain lasting longer than three months — affects an estimated 50 million adults in the United States alone. For many of these patients, conventional treatments including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, and physical therapy provide inadequate relief. Ketamine has emerged as a valuable tool in the management of certain chronic pain conditions, particularly those involving neuropathic pain and central sensitization.

The use of ketamine for pain is grounded in its pharmacological mechanism. As an NMDA receptor antagonist, ketamine blocks a key receptor involved in pain processing, wind-up phenomena, and the development of central sensitization — a state in which the central nervous system amplifies pain signals. By interrupting these processes, ketamine can provide relief where other analgesics fail.

Conditions Treated

Complex Regional Pain Syndrome (CRPS)

CRPS is one of the best-studied indications for ketamine in pain management. This condition involves severe, often burning pain in a limb, usually following an injury. CRPS is believed to involve both peripheral and central sensitization, and it can be extremely difficult to treat with conventional analgesics.

Multiple studies have demonstrated that ketamine infusions can significantly reduce CRPS pain scores, with some patients experiencing weeks to months of relief after a multi-day infusion protocol. Specialized pain centers may use higher doses and longer infusion durations for CRPS than those typically used for psychiatric conditions.

Neuropathic Pain

Neuropathic pain — caused by damage to or dysfunction of the nervous system — includes conditions such as diabetic neuropathy, post-herpetic neuralgia, and nerve injury pain. NMDA receptor activation plays a central role in the maintenance of neuropathic pain, making ketamine a mechanistically logical treatment option.

Clinical trials have shown that ketamine infusions can reduce neuropathic pain intensity, though the duration of relief varies. Some patients require periodic maintenance infusions to sustain the benefit. For more on how long ketamine's therapeutic effects last, see our FAQ.

Fibromyalgia

Fibromyalgia is a chronic widespread pain condition associated with central sensitization, fatigue, and cognitive difficulties. Several studies have evaluated ketamine for fibromyalgia, with results showing moderate pain reduction in a subset of patients. The response appears to be most pronounced in patients with evidence of central sensitization on quantitative sensory testing.

Migraine and Headache Disorders

Emerging evidence suggests that ketamine may benefit some patients with refractory migraine and chronic daily headache. Some headache centers offer ketamine infusions for patients who have failed multiple preventive and acute treatments. The evidence base, while growing, remains limited compared to other pain conditions.

How Ketamine Treats Pain

Ketamine addresses chronic pain through several complementary mechanisms:

• NMDA receptor blockade — By blocking NMDA receptors in the spinal cord and brain, ketamine interrupts the transmission and amplification of pain signals. This is particularly relevant for conditions involving central sensitization, where the nervous system has become hypersensitive to pain.
• Anti-inflammatory effects — Ketamine has demonstrated anti-inflammatory properties at both central and peripheral levels, which may contribute to pain relief in conditions with an inflammatory component.
• Opioid-sparing effect — Ketamine can reduce opioid requirements when used as part of a multimodal analgesic strategy, potentially lowering the risk of opioid-related side effects and dependence.
• Resetting pain pathways — Some researchers propose that ketamine infusions can "reset" maladaptive pain processing circuits, providing a sustained reduction in pain sensitivity that outlasts the direct pharmacological effects of the drug.

Treatment Protocols for Pain

Pain-focused ketamine protocols differ from those used for psychiatric conditions:

• Dosing — Pain infusions often use higher doses than psychiatric infusions, sometimes ranging from 0.5 mg/kg to 1 mg/kg per hour over several hours.
• Duration — Multi-day infusion protocols (3-5 consecutive days) are common for conditions like CRPS.
• Setting — Pain infusions may be administered in outpatient infusion centers, pain clinics, or in some cases, inpatient hospital settings for more intensive protocols.
• Monitoring — Continuous cardiac monitoring, pulse oximetry, and blood pressure monitoring are standard during pain infusions.

Evidence and Limitations

While the evidence supporting ketamine for chronic pain is promising, it is important to acknowledge its limitations:

• Most studies have been small and not all have included placebo controls
• The duration of pain relief is variable and often temporary
• Optimal dosing protocols have not been definitively established
• Long-term safety data for repeated infusions are still being collected
• Not all chronic pain conditions respond equally to ketamine

Professional guidelines from organizations such as the American Society of Regional Anesthesia (ASRA) and the American Academy of Pain Medicine (AAPM) have issued consensus statements acknowledging ketamine's role in chronic pain management while calling for larger, more rigorous trials.

Integration With Other Treatments

Ketamine for chronic pain is most effective when integrated into a multidisciplinary pain management program. Learn more about how ketamine works in the brain to understand its unique mechanism of action. This may include physical therapy, cognitive behavioral therapy for pain, medication optimization, interventional procedures, and lifestyle modifications. Ketamine should be viewed as one component of a comprehensive pain management strategy rather than a standalone solution.

References

• MedlinePlus: Chronic Pain — National Library of Medicine overview of chronic pain conditions, treatment options, and management approaches
• StatPearls: Ketamine — Clinical reference on ketamine's analgesic mechanisms and use in pain management
• MedlinePlus: Ketamine Injection — Drug information on ketamine, including its approved anesthetic and analgesic indications
• Ketamine Pharmacology: An Update — NIH review of ketamine pharmacodynamics relevant to NMDA receptor-mediated pain pathways